Company Search:
Advanced Search
Sponsored Links
Divi's Laboratories Limited Company Snapshot
Divi's Laboratories Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Divi's Laboratories Limited with three other companies in this sector in India: Strides Shasun Ltd (2016 sales of 31.56 billion Indian Rupees [US$486.39 million] of which 100% was Pharma), Alembic Pharmaceuticals Ltd (31.49 billion Indian Rupees [US$485.22 million] of which 100% was Pharmaceuticals), and Wockhardt Limited (44.61 billion Indian Rupees [US$687.51 million] of which 100% was Pharmaceuticals).

Sales Analysis. Divi's Laboratories Limited reported sales of 37.76 billion Indian Rupees (US$581.94 million) for the fiscal year ending March of 2016. This represents an increase of 21.2% versus 2015, when the company's sales were 31.15 billion Indian Rupees. Sales at Divi's Laboratories Limited have increased during each of the previous five years (and since 2011, sales have increased a total of 189%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Divi's Laboratories Limited
  Stock Performance Chart for Divi's Laboratories Limited
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 611.00
(Figures in Indian Rupees)
1 Week -2.4%   13 Weeks -3.1%  
4 Weeks -18.4%   52 Weeks -41.4%  
Divi's Laboratories Limited Key Data:
  Ticker: DIVISLAB Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 37,763,616,000
(Year Ending Jan 2017).
Employees: 3,708
  Currency: Indian Rupees Market Cap: 162,201,302,380
  Fiscal Yr Ends: March Shares Outstanding: 265,468,580
  Share Type: Ordinary Closely Held Shares: 138,582,708
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.